Evidence map›Paper›PMID 35229716›Full record

ArticleeLife2022

Coil-to-α-helix transition at the Nup358-BicD2 interface activates BicD2 for dynein recruitment.

James M Gibson, Heying Cui, M Yusuf Ali, Xiaoxin Zhao, Erik W Debler, Jing Zhao, Kathleen M Trybus, Sozanne R Solmaz, Chunyu Wang

Open access · goldAbstract read
In one paragraph

Article in eLife, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Advances in the understanding of nuclear pore complexes in human diseases.Journal of cancer research and clinical oncology · 2024
    Review
  11. Article
  12. Positioning centrioles and centrosomes.The Journal of cell biology · 2024
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

James M Gibson *Department of Biological Sciences, Department of Chemistry and Chemical Biology, Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, Troy, United States.ORCID 0000-0002-9378-0135
Heying Cui *Department of Chemistry, Binghamton University, Binghamton, United States.
M Yusuf Ali *Department of Molecular Physiology and Biophysics, Larner College of Medicine, University of Vermont, Burlington, United States.ORCID 0000-0003-2164-3323
Xiaoxin ZhaoDepartment of Chemistry, Binghamton University, Binghamton, United States.
Erik W DeblerLaboratory of Cell Biology, The Rockefeller University, New York, United States.ORCID 0000-0002-2587-2150
Jing ZhaoDepartment of Biological Sciences, Department of Chemistry and Chemical Biology, Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, Troy, United States.
Kathleen M TrybusDepartment of Molecular Physiology and Biophysics, Larner College of Medicine, University of Vermont, Burlington, United States.ORCID 0000-0002-5583-8500
Sozanne R SolmazDepartment of Chemistry, Binghamton University, Binghamton, United States.ORCID 0000-0002-1703-3701
Chunyu WangDepartment of Biological Sciences, Department of Chemistry and Chemical Biology, Center for Biotechnology and Interdisciplinary Studies, Rensselaer Polytechnic Institute, Troy, United States.ORCID 0000-0001-5165-7959
Binghamton University · USRensselaer Polytechnic Institute · USUniversity of Vermont · USRockefeller University · US

Funding

Training and OutreachP30GM124166 · NIGMS · CORNELL UNIVERSITY · PI RICHARD A. CERIONE · 2019 to 2026
$28.3M
Chemical Approaches to Control the Function of Regulatory RNAsR35GM130207 · NIGMS · STATE UNIVERSITY OF NY,BINGHAMTON · PI ERIKS ROZNERS · 2019 to 2026
$3.7M
Heparan Sulfate 3-O-Sulfation in Transcellular Propagation of Tauopathy in Alzheimer's DiseaseRF1AG069039 · NIA · RENSSELAER POLYTECHNIC INSTITUTE · PI LINHARDT, ROBERT J, LIU, JIAN · 2020 to 2020
$2.6M
Molecular Structural Basis of Non-specific Neuronal Membrane Disruption Induced by Early-Stage Beta-Amyloid Peptide AggregationR01GM125853 · NIGMS · STATE UNIVERSITY OF NY,BINGHAMTON · PI Wei Qiang · 2018 to 2026
$2.5M
Molecular Mechanisms of Motility Deduced from in Vitro Reconstituted Microtubule- and Actin-Based Motor ComplexesR35GM136288 · NIGMS · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI KATHLEEN M TRYBUS · 2020 to 2026
$2.5M
Structural Mechanisms of Hedgehog Autoprocessing in Physiology and DiseaseR01CA206592 · NCI · RENSSELAER POLYTECHNIC INSTITUTE · PI CALLAHAN, BRIAN PATRICK, WANG, CHUNYU · 2017 to 2021
$2.0M
Regulation of bidirectional transport of the nucleus by adapter proteinsR01GM144578 · NIGMS · STATE UNIVERSITY OF NY,BINGHAMTON · PI SOLMAZ, SOZANNE R · 2022 to 2025
$1.6M
A NEW HYBRID DIFFRACTOMETER FOR MACROMOLECULAR CRYSTALLOGRAPHY AND SAXS AT TJUS10OD017987 · OD · THOMAS JEFFERSON UNIVERSITY · PI CINGOLANI, GINO · 2014 to 2014
$600k
Heparan Sulfate 3-O-Sulfation in Transcellular Propagation of Tauopathy in Alzheimer's DiseaseR01AG069039 · NIA · RENSSELAER POLYTECHNIC INSTITUTE · PI LINHARDT, ROBERT J, LIU, JIAN · 2024 to 2024
$555k
Cell cycle-specific recognition of the cell nucleus as cargo for dynein-dependent transportR15GM128119 · NIGMS · STATE UNIVERSITY OF NY,BINGHAMTON · PI SOLMAZ, SOZANNE R · 2018 to 2018
$449k
Single-molecule approaches to probe the regulation of kinesin and dynein-driven cargo transport by an adapter proteinR03NS114115 · NINDS · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI ALI, M YUSUF · 2020 to 2020
$156k
A High-Throughput Crystallization Platform at JeffersonS10OD023479 · OD · THOMAS JEFFERSON UNIVERSITY · PI CINGOLANI, GINO · 2019 to 2019
$94k
NCI NIH HHS R01 CA206592NIA NIH HHS R01 AG069039NIA NIH HHS RF1 AG069039NIGMS NIH HHS P30 GM124166NIGMS NIH HHS R01 GM125853NIGMS NIH HHS R01 GM144578NIGMS NIH HHS R15 GM128119NIGMS NIH HHS R35 GM130207NIGMS NIH HHS R35 GM136288NIH HHS S10 OD017987NIH HHS S10 OD023479NINDS NIH HHS R03 NS114115
6 · The paper itself

Abstract

Nup358, a protein of the nuclear pore complex, facilitates a nuclear positioning pathway that is essential for many biological processes, including neuromuscular and brain development. Nup358 interacts with the dynein adaptor Bicaudal D2 (BicD2), which in turn recruits the dynein machinery to position the nucleus. However, the molecular mechanisms of the Nup358/BicD2 interaction and the activation of transport remain poorly understood. Here for the first time, we show that a minimal Nup358 domain activates dynein/dynactin/BicD2 for processive motility on microtubules. Using nuclear magnetic resonance titration and chemical exchange saturation transfer, mutagenesis, and circular dichroism spectroscopy, a Nup358 α-helix encompassing residues 2162-2184 was identified, which transitioned from a random coil to an α-helical conformation upon BicD2 binding and formed the core of the Nup358-BicD2 interface. Mutations in this region of Nup358 decreased the Nup358/BicD2 interaction, resulting in decreased dynein recruitment and impaired motility. BicD2 thus recognizes Nup358 through a 'cargo recognition α-helix,' a structural feature that may stabilize BicD2 in its activated state and promote processive dynein motility.

Indexed as

DyneinsMicrotubule-Associated ProteinsMolecular ChaperonesNuclear Pore Complex ProteinsDynactin ComplexMicrotubulesProtein Conformation, alpha-HelicalDynactin ComplexDyneinsMicrotubule-Associated ProteinsMolecular ChaperonesNuclear Pore Complex ProteinsBicD2bidirectional transportdyneinmolecular biophysicsNMRnonenuclear positioningstructural biologyTIRF

Identifiers

PMID35229716
PMCPMC8956292
OpenAlexW4214840473

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.